Kardiochirurgia dorosłych <BR>Long-term angiotensin converting enzyme inhibition and postoperative risk of atrial fibrillation following coronary artery bypass grafting

Krzysztof Szyndler; Piotr Siondalski; Rafał Pawlaczyk; Krzysztof Jarmoszewicz; Grzegorz Łaskawski; Andrzej Łoś; Dariusz Jagielak; Jan Rogowski

eISSN: 1897-4252
ISSN: 1731-5530

Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

3/2006
vol. 3

Send email

Copy url:

abstract:

Kardiochirurgia dorosłych
Long-term angiotensin converting enzyme inhibition and postoperative risk of atrial fibrillation following coronary artery bypass grafting

Krzysztof Szyndler

,

Piotr Siondalski

,

Rafał Pawlaczyk

,

Krzysztof Jarmoszewicz

,

Grzegorz Łaskawski

,

Andrzej Łoś

,

Dariusz Jagielak

,

Jan Rogowski

Kardiochir Torakochir Pol 2006; 3 (3): 264–269

Online publish date: 2006/09/15

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Szyndler K, Siondalski P, Pawlaczyk R, et al. Kardiochirurgia dorosłych Long-term angiotensin converting enzyme inhibition and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery. 2006;3(3):264-269.

APA

Szyndler, K., Siondalski, P., Pawlaczyk, R., Jarmoszewicz, K., Łaskawski, G.,  & Łoś, A. et al. (2006). Kardiochirurgia dorosłych Long-term angiotensin converting enzyme inhibition and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery, 3(3), 264-269.

Chicago

Szyndler, Krzysztof, Piotr Siondalski, Rafał Pawlaczyk, Krzysztof Jarmoszewicz, Grzegorz Łaskawski, Andrzej Łoś,  and Dariusz Jagielak et al. 2006. "Kardiochirurgia dorosłych Long-term angiotensin converting enzyme inhibition and postoperative risk of atrial fibrillation following coronary artery bypass grafting". Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery 3 (3): 264-269.

Harvard

Szyndler, K., Siondalski, P., Pawlaczyk, R., Jarmoszewicz, K., Łaskawski, G., Łoś, A., Jagielak, D.,  and Rogowski, J. (2006). Kardiochirurgia dorosłych Long-term angiotensin converting enzyme inhibition and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery, 3(3), pp.264-269.

MLA

Szyndler, Krzysztof et al. "Kardiochirurgia dorosłych Long-term angiotensin converting enzyme inhibition and postoperative risk of atrial fibrillation following coronary artery bypass grafting." Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery, vol. 3, no. 3, 2006, pp. 264-269.

Vancouver

Szyndler K, Siondalski P, Pawlaczyk R, Jarmoszewicz K, Łaskawski G, Łoś A et al. Kardiochirurgia dorosłych Long-term angiotensin converting enzyme inhibition and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery. 2006;3(3):264-269.

Background: Postoperative atrial fibrillation (PAF) occurs in up to 50% of patients and represents the most common complication after coronary artery bypass grafting (CABG). Recent studies demonstrated significant reduction of paroxysmal AF in patients with heart failure or left ventricle hypertrophy treated with angiotensin-converting enzyme inhibitors (ACEI). AIM of the study was to determine whether chronic ACEI therapy has an impact on the incidence of PAF after CABG.
Materials and methods: The study was performed on 360 patients with coronary artery disease. 255 patients receiving ACEI and 105 patients without ACEI underwent isolated CABG.
Results: Postoperative AF was observed in 20.4% of subjects of the ACEI group and 32.4% of controls (p=0.015). ACEI therapy was the only independent factor reducing the risk of PAF (OR 0.44; 95% CI 0.25-0.78; p <0.001). Relative risk reduction of PAF for ACEI therapy equals 37%.
Conclusion: Long-term ACEI therapy significantly reduces PAF in patients after CABG.

keywords:

Kardiochirurgia dorosłych Long-term angiotensin converting enzyme inhibition and postoperative risk of atrial fibrillation following coronary artery bypass grafting

Krzysztof Szyndler , Piotr Siondalski , Rafał Pawlaczyk , Krzysztof Jarmoszewicz , Grzegorz Łaskawski , Andrzej Łoś , Dariusz Jagielak , Jan Rogowski

CABG, postoperative atrial fibrillation, ACE-inhibitor

Kardiochirurgia dorosłych
Long-term angiotensin converting enzyme inhibition and postoperative risk of atrial fibrillation following coronary artery bypass grafting

Krzysztof Szyndler

,

Piotr Siondalski

,

Rafał Pawlaczyk

,

Krzysztof Jarmoszewicz

,

Grzegorz Łaskawski

,

Andrzej Łoś

,

Dariusz Jagielak

,

Jan Rogowski